(19)
(11) EP 1 622 455 A2

(12)

(88) Date of publication A3:
03.02.2005

(43) Date of publication:
08.02.2006 Bulletin 2006/06

(21) Application number: 04751195.1

(22) Date of filing: 30.04.2004
(51) International Patent Classification (IPC): 
A01N 45/00(1985.01)
C07C 1/00(1968.09)
(86) International application number:
PCT/US2004/013703
(87) International publication number:
WO 2004/098522 (18.11.2004 Gazette 2004/47)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
LT LV

(30) Priority: 30.04.2003 US 466638 P

(71) Applicants:
  • Bioxell S.p.a.
    20132 Milano (IT)
  • UNIVERSITY OF CHICAGO
    Chicago, IL 60637 (US)

(72) Inventors:
  • ADORINI, Luciano
    I-20133 Milano (IT)
  • PENNA, Guiseppe
    I-20095 Cusano (IT)
  • USKOKOVIC, Milan, R.
    Upper Montclair, NJ 07043 (US)
  • MAEHR, Hubert
    Wayne, NJ 07470 (US)
  • LI, Yan, Chun
    Chicago, IL60637 (US)

(74) Representative: Teuten, Andrew John et al
Sagittarius Intellectual Property Consultants Ltd Taylor House 39 High Street
Marlow, Bucks. SL7 1AF
Marlow, Bucks. SL7 1AF (GB)

   


(54) GEMINI VITAMIN D3 COMPOUNDS AND METHODS OF USE THEREOF